Thailand Influenza Drug Market to 2032
Overview
The Thailand Influenza Drug Market is expected to reach a 139.59 USD Million by 2032 and is projected to grow at a CAGR of 6.12% from 2025 to 2032.
Revenue, 2024 (USD Million)
95.06
Forecast, 2032 (USD Million)
139.59
CAGR, 2024 - 2032
6.12%
Report Coverage
Thailand
Thailand Influenza Drug Market 2018-2032 USD Million
Thailand Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 95.06 USD Million
- Projected Market Size (2032): 139.59 USD Million
- CAGR (2025-2032): 6.12%
Key Findings of Thailand Influenza Drug Market
- The Thailand Influenza Drug Market was valued at 95.06 USD Million in 2024.
- The Thailand Influenza Drug Market is likely to grow at a CAGR of 6.12% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 165.31 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 6.91% during the forecast period from 2024 to 2032.
Thailand Influenza Drug Market Scope
Thailand Influenza Drug Market Segmentation & Scope
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Type
- Influenza C
- Influenza B
- Influenza A
Thailand Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 95.06 USD Million |
| Market Value in 2032 | 139.59 USD Million |
| CAGR (2025-2032) | 6.12% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment,Route of Administration,Age,End User,Distribution Channel,Type |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 95.06 USD Million in 2024
- Key Country: Thailand, leading in terms of revenue with value of 95.06 USD Million in 2024.
Segments and Scope
-
Thailand Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 165.31 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 6.14 % in forecast period 2025-2032.
-
Thailand Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 40.91 USD Million in the year 2024.
- Oral is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 6.91 % in forecast period 2025-2032.
-
Thailand Influenza Drug Market to 2032, By Age
- Adults is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 47.58 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 5.66 % in forecast period 2025-2032.
-
Thailand Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 68.71 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 6.29 % in forecast period 2025-2032.
-
Thailand Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 52.76 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 6.45 % in forecast period 2025-2032.
-
Thailand Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in Thailand Influenza Drug Market to 2032 with a revenue of 44.57 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in Thailand Influenza Drug Market to 2032 with a Growth rate of 6.63 % in forecast period 2025-2032.
Thailand Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
Thailand Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
Thailand Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Thailand Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
Thailand Influenza Drug Market was valued at USD 95.06(Revenue in USD Million) in 2022.
Thailand Influenza Drug Market is projected to grow at a CAGR of 6.12% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Thailand Influenza Drug Market, holding a largest market share of 165.31 USD Million in 2024
Thailand Influenza Drug Market Scope
Thailand Influenza Drug Market Segmentation & Scope
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Type
- Influenza C
- Influenza B
- Influenza A
Frequently Asked Questions
The Thailand Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
Thailand Influenza Drug Market was valued at USD 95.06(Revenue in USD Million) in 2022.
Thailand Influenza Drug Market is projected to grow at a CAGR of 6.12% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Influenza Drug Market for final year is USD 139.59 (USD Million).
Thailand Influenza Drug Market Company Profiling
Frequently Asked Questions
The Thailand Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
Thailand Influenza Drug Market was valued at USD 95.06(Revenue in USD Million) in 2022.
Thailand Influenza Drug Market is projected to grow at a CAGR of 6.12% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Influenza Drug Market for final year is USD 139.59 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.